Membrane-Based Water for Injection

Amidst the massive technological and social changes upending the societal status quo, the culture of doctors around the globe is also in flux according to The Truth About Doctors, a new global research study conducted by McCann Health, in partnership with McCann Truth Central. This landmark study which surveyed nearly 2,000 doctors in 16 markets, found that the practice of medicine is not everything doctors thought it would be. In fact, the expectations of the job are startling mismatched to the realities of the high-volume, cost-cutting, technology-driven health environment we live in today. There is a massive gap between expectations and reality for doctors around the globe that is impacting their ability to do their job, as well as their enthusiasm for it.

In order to keep competitive, pharma firms and their partners must keep current with the latest developments in drug delivery.

Incorporation of patient-focused drug design principles is increasingly becoming essential to ensure that a new drug is commercially successful and delivers the best patient outcomes. Often, patient factors and insights are not considered or discovered until the later phases of drug development when dose form, dose strength, and route of administration are already decided. There is tremendous potential benefit of equipping formulators and other scientists with patient insights earlier in the development process so that the drug product can be designed to address the specific needs of target patient populations.

The Pharmaceutical Industry has a strong need to develop knowledge from data. Although the latter is not at a premium in the Pharmaceutical Industry the former is, as always, at a premium. Multivariate data analysis (MVA) is a set of statistical data analytical methods which has been widely adopted within the Pharmaceutical Industry, and it has pre-eminence within the discipline.